Hui Zhang

10PUBLICATIONS
38CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 13, 2025
PSGL-1 is a phagocytosis checkpoint that enables tumor escape from macrophage clearance.

Cheng Zhong, Lixiang Wang, Yujia Liu

|Aug 29, 2024
Identification of clinical prognosis features and significant DNA methylation regulation in pineoblastoma.

Kongfeng Shao, Haojie Zhu, Xijin Lin

|Apr 09, 2023
Anti-CLL1-based CAR T-cells with 4-1-BB or CD28/CD27 stimulatory domains in treating childhood refractory/relapsed acute myeloid leukemia.

Kunlin Pei, Haoyu Xu, Pengfei Wang

|Apr 20, 2022
Dasatinib-therapy induced sustained remission in a child with refractory TCF7-SPI1 T-cell acute lymphoblastic leukemia.

Yingyi He, Jingliao Zhang, Yingchi Zhang

|Feb 22, 2022
Genome-wide CRISPR/Cas9 screening identifies determinant of panobinostat sensitivity in acute lymphoblastic leukemia.

Chuang Jiang, Maoxiang Qian, Yoshihiro Gocho

|Jul 22, 2021
Toward the Cure of Acute Lymphoblastic Leukemia in Children in China.

Si-Liang Chen, Hui Zhang, Robert Peter Gale

Pageof 2

Frequent Collaborators

3 joint publications

Ching-Hon Pui

3 joint publications

Yingyi He

1 joint publications

Paul B Koller

1 joint publications

Hagop Kantarjian